Analysis of Cutaneous and Hematologic Disorders by High-Throughput Nucleic Acid Sequencing
| Status: | Recruiting |
|---|---|
| Conditions: | Skin and Soft Tissue Infections, Infectious Disease, Lymphoma, Hematology |
| Therapuetic Areas: | Dermatology / Plastic Surgery, Hematology, Immunology / Infectious Diseases, Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 6/16/2016 |
| Start Date: | June 2011 |
| End Date: | April 2017 |
| Contact: | Alexander Ungewickell |
| Email: | ungewica@stanford.edu |
| Phone: | 650-723-6661 |
The goal of this study is to identify genetic changes associated with the initiation,
progression, and treatment response of response of cutaneous and hematologic disorders using
recently developed high-throughput sequencing technologies. The improved understanding of
the genetic changes associated with cutaneous and hematologic disorders may lead to improved
diagnostic, prognostic and therapeutic options for these disorders.
progression, and treatment response of response of cutaneous and hematologic disorders using
recently developed high-throughput sequencing technologies. The improved understanding of
the genetic changes associated with cutaneous and hematologic disorders may lead to improved
diagnostic, prognostic and therapeutic options for these disorders.
Inclusion Criteria:
- 18 years of age or older
- Patient meets the clinical and/or pathologic criteria for the cutaneous or
hematologic disorder being examined.
- Patient is willing to provide skin biopsies and five 10 mL tubes of peripheral blood.
Exclusion Criteria:
- Less than 18 years of age
We found this trial at
1
site
Stanford University School of Medicine Vast in both its physical scale and its impact on...
Click here to add this to my saved trials
